ARCHIVES

FDA Advisors Oppose Group’s Tamoxifen Trial, But Okay The Idea

This article is from The Cancer Letter archive.

Vol. 16 No. 27 | July 6, 1990

Download PDF Visit The Full Archive

Related Articles

Abstracts Of Papers Presented By Breast Cancer Task Force

September 17, 1976

Wyngaarden List, Reportedly Six-Seven Names For NCI Director, Goes to White House This Week

November 11, 1988

Virology Contract Phaseout To Cut $5 Million In FY 1980; Bigger reduction Coming In 1982

July 27, 1979

CCOPs Favor Ability To Enter Patients On Any Group Study

June 12, 1998

CMS Advisors Express Low Confidence In Low-Dose CT Screening for Lung Cancer

May 9, 2014

FDA Likely To Change Procedures For Patient Interaction, Official Says

November 10, 1995